Asia On The Move: Stryker Changes China Structure; Shanghai Names New Health Commissioner
This article was originally published in PharmAsia News
Device manufacturer Stryker appointed a new president to oversee both Stryker China and subsidiary Trauson. Shanghai names a new health commissioner after the arrest of its deputy commissioner. SciClone appoints VP of compliance and changes also take place at China FDA, Chugai and Teijin Pharma.